Skip to main content
SpringerLink
Log in

Hidradenitis Suppurativa

  • Chapter
European Handbook of Dermatological Treatments

Abstract

Hidradenitis suppurativa / acne inversa (HS) is a chronic, multifactorial, debilitating, inflammatory skin appendage condition of the hair follicle. The clinical lesions of HS consist of recurrent painful nodules and abscesses, sinus tracts, hypertrophic scars and pseudocomedones, in the apocrine gland-bearing areas of the body. Management of HS should encompass the education of the patient regarding the nature of the disease, general measures, medical topical or systemic treatment and surgical therapy. According to the European Dermatology Forum guidelines, locally recurrent lesions can be treated by surgery or laser, whereas medical treatment (alone or combined with surgery) is more appropriate for widely spread lesions. Topical clindamycin 1% is the only studied topical antibiotic for HS. Systemic treatments for HS may include antibiotics (clindamycin plus rifampicin, tetracyclines), acitretin and biologic agents (adalimumab, infliximab). The treatment choice will mainly depend on the severity and extent (localized or widespread disease) of HS.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Boer, et al. Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer? Br J Dermatol. 2011;164:170–5.

    Article  CAS  Google Scholar 

  • Brocard A, et al. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Dermatology. 2007;214:325–7.

    Article  CAS  Google Scholar 

  • Dessinioti C, Katsambas AD, Antoniou C. Hidradenitis suppurativa as a systemic disease. Clin Dermatol 2014;32:397–408.

    Google Scholar 

  • Gener G, Canoui-Poitrine F, Revuz JE, et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology. 2009;219:148–54.

    Article  CAS  Google Scholar 

  • Hana A, Booken D, Henrich C, et al. Functional significance of non-neuronal acetylcholine in skin epithelia. Life Sci. 2007;80:2214–20.

    Article  CAS  Google Scholar 

  • Matusiak L, Bieniek A, Szepietowski C. Increased serum tumour necrosis factor-α in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-α agents? Acta Derm Venereol. 2009;89:601–3.

    Article  CAS  Google Scholar 

  • Mendonca CO, Griffiths CEM. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol. 2006;154:977–8.

    Article  CAS  Google Scholar 

  • van der Zee HH, Prens EP. The anti-inflammatory drug colchicine lacks efficacy in hidradenitis suppurativa. Dermatology. 2011;223:169–73.

    Article  Google Scholar 

  • Van der Zee HH, Boer J, Prens EP, Jemec GBE. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology. 2009;219:143–7.

    Article  Google Scholar 

  • Van der Zee HH, Prens EP, Boer J. Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol. 2010;63:475–80.

    Article  Google Scholar 

  • Zouboulis CC, Bechara FG, Fritz K, Kurzen H, Liakou AI, Marsch WC, Milling A, Nast A, Podda M, Taube KM, Wienert V, Winkler T. S1 – Leitlinie zur Therapie der Hidradenitis suppurativa/Acne inversa (ICD-10 Ziffer: L73.2). J Dtsch Dermatol Ges. 2012;10 Suppl 5:S1–31.

    Article  Google Scholar 

  • Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa /acne inversa. J Eur Acad Dermatol Venereol 2014; in press.

    Google Scholar 

Further Reading

  • Bettoli V, Zauli S, Borghi A, et al. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients. J Eur Acad Dermatol. 2014;28:125–6.

    Google Scholar 

  • Bianch L, Hansel K, Stingeni L. Recalcitrant severe hidradenitis suppurativa successfully treated with cyclosporine A. J Am Acad Dermatol. 2012;67:e278–9.

    Article  Google Scholar 

  • Blok JL, van Hattem S, Jonkman MF, Horvath B. Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systemic review. Br J Dermatol. 2013;168:243–52.

    Article  CAS  Google Scholar 

  • Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T. Pyoderma gangrenosum, acne and suppurative hidradenitis (PASH)- a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol. 2012;66:409–15.

    Article  Google Scholar 

  • Canoui-Poitrine F, Le Thuaut A, Revuz JE, et al. Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study. J Invest Dermatol. 2013;133:1506–11.

    Article  CAS  Google Scholar 

  • Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol. 1983;22:325–8.

    Article  CAS  Google Scholar 

  • Fimmel S, Zouboulis CC. Comorbidities of hidradenitis suppurativa (acne inversa). Derm-Endocrinol. 2010;2:9–16.

    Article  Google Scholar 

  • Giamarellos–Bourboulis EJ, Antonopoulou A, Petropoulou C, et al. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol. 2007;156:51–6.

    Article  Google Scholar 

  • Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 1998;39:971–4.

    Article  CAS  Google Scholar 

  • Kurzen H, Kurokawa K, Jemec GBE, et al. What causes hidradenitis suppurativa? Exp Dermatol. 2008;17:455–72.

    Article  CAS  Google Scholar 

  • Mahmoud BH, Tiemey E, Hexsel CI, et al. Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium: yttrium-aluminium-garnet laser. J Am Acad Dermatol. 2010;62:637–45.

    Article  Google Scholar 

  • Passeron T, Khemis A, Ortonne JP. Pulsed dye laser-mediated photodynamic therapy for acne inversa is not successful: a pilot study on four cases. J Dermatol Treat. 2009;20:297–8.

    Article  CAS  Google Scholar 

  • Revuz JE, Canoui-Poitrine F, Wolkenstein P, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008;59:596–601.

    Article  Google Scholar 

  • Savva A, Kanni T, Damoraki G, et al. Impact of Toll-like receptor-4 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa. Br J Dermatol. 2013;168:311–7.

    Article  CAS  Google Scholar 

  • van der Zee HH, de Ruiter L, van den Broecke DG, et al. Elevated levels of tumour necrosis factor (TNF)–α, interleukin (IL)–1α and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1α. Br J Dermatol. 2011;164:1292–8.

    Article  Google Scholar 

  • Verdolini R, Clayton N, Smith A, et al. Metformin for the treatment of hidradenitis suppurativa: a little help along the way. J Eur Acad Dermatol Venereol. 2013;27:1101–8.

    Article  CAS  Google Scholar 

  • Wall D. Rifampicin and clindamycin for hidradenitis. J Am Acad Dermatol. 2011;64:790.

    Article  Google Scholar 

  • Zouboulis CC, Tsatsou F. Disorders of the apocrine sweat glands. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw Hill; 2012. p. 947–59.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Andreas Syggros Hospital, University of Athens, Athens, Greece

    Clio Dessinioti

  2. Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Dessau, Germany

    Christos Zouboulis

Authors
  1. Clio Dessinioti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christos Zouboulis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Clio Dessinioti .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Andreas Syggros Hospital University of Athens, Athens, Greece

    Andreas D. Katsambas  & Clio Dessinioti  & 

  2. University of Rome “G. Marconi”, Rome, Italy

    Torello M. Lotti

  3. Centro Studi per la Ricerca Multidisciplinare Rigenerativa (CSRMR), Rome, Italy

    Torello M. Lotti

  4. Unit of Dermatology, University of Pisa, Pisa, Italy

    Angelo Massimiliano D’Erme

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dessinioti, C., Zouboulis, C. (2015). Hidradenitis Suppurativa. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D’Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45139-7_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45139-7_42

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45138-0

  • Online ISBN: 978-3-662-45139-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation